Chengdu Seventh People's Hospital

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease1 trial
• Fatty liver disease (MASLD/MASH)1 trial
• Obesity1 trial
• Stroke1 trial

Phase

• Phase 22 trials

Status

• Completed2 trials
• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Dongzhimen Hospital, Beijing1 trial
• Harbin Medical University1 trial
• Hinova Pharmaceuticals Inc.1 trial
• Shanghai Pharmaceuticals Holding Co., Ltd1 trial

Running trials

• Active, not recruiting

  Time-Restricted Eating for Weight-Loss Maintenance

  NCT07163455· Harbin Medical University· Source

• Recruiting

  A Trial to Evaluate the Efficacy, Safety, PK, and PD of HP515 in Non - Alcoholic Fatty Liver Disease ( NASH/MASH )

  NCT07308548· Phase 2· Hinova Pharmaceuticals Inc.· Source

  Contact: Liu JingYu LJY chief physician

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fatty liver disease (MASLD/MASH)1 recruiting

Closed trials

• Completed

  Outcomes After Intravenous Alteplase / Tenecteplase With or Without Shuxuetong Injection in Routine Clinical Practice

  NCT06018181· Dongzhimen Hospital, Beijing· Source

• Completed

  Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease

  NCT05593575· Phase 2· Shanghai Pharmaceuticals Holding Co., Ltd· Source